These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1208 related articles for article (PubMed ID: 11923519)

  • 1. Matrix metalloproteinase inhibitors and cancer: trials and tribulations.
    Coussens LM; Fingleton B; Matrisian LM
    Science; 2002 Mar; 295(5564):2387-92. PubMed ID: 11923519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinase inhibitors.
    Ramnath N; Creaven PJ
    Curr Oncol Rep; 2004 Mar; 6(2):96-102. PubMed ID: 14751086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy.
    Overall CM; Kleifeld O
    Nat Rev Cancer; 2006 Mar; 6(3):227-39. PubMed ID: 16498445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural bio-drugs as matrix metalloproteinase inhibitors: new perspectives on the horizon?
    Mannello F
    Recent Pat Anticancer Drug Discov; 2006 Jan; 1(1):91-103. PubMed ID: 18221029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinase inhibitors.
    Wojtowicz-Praga SM; Dickson RB; Hawkins MJ
    Invest New Drugs; 1997; 15(1):61-75. PubMed ID: 9195290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress in the development of matrix metalloproteinase inhibitors.
    Tu G; Xu W; Huang H; Li S
    Curr Med Chem; 2008; 15(14):1388-95. PubMed ID: 18537616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of matrix metalloproteinases in patients with malignant tumors].
    Stanciūte D; Didziapetriene J; Kadziauskas J
    Medicina (Kaunas); 2004; 40(12):1143-50. PubMed ID: 15630339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase inhibitors: do they have a place in anticancer therapy?
    Rudek MA; Venitz J; Figg WD
    Pharmacotherapy; 2002 Jun; 22(6):705-20. PubMed ID: 12066962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinase inhibitors for cancer therapy:the current situation and future prospects.
    Fingleton B
    Expert Opin Ther Targets; 2003 Jun; 7(3):385-97. PubMed ID: 12783574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix Metalloproteinase Inhibitors in Cancer Therapy: Turning Past Failures Into Future Successes.
    Winer A; Adams S; Mignatti P
    Mol Cancer Ther; 2018 Jun; 17(6):1147-1155. PubMed ID: 29735645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer.
    Radisky ES; Radisky DC
    J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):201-12. PubMed ID: 20440544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinase inhibitors as anticancer therapeutics.
    Mannello F; Tonti G; Papa S
    Curr Cancer Drug Targets; 2005 Jun; 5(4):285-98. PubMed ID: 15975049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamic considerations in the use of matrix metalloproteinase inhibitors in cancer treatment.
    Yang JS; Lin CW; Su SC; Yang SF
    Expert Opin Drug Metab Toxicol; 2016; 12(2):191-200. PubMed ID: 26852787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of matrix metalloproteinase inhibitors in cancer therapy.
    Hidalgo M; Eckhardt SG
    J Natl Cancer Inst; 2001 Feb; 93(3):178-93. PubMed ID: 11158186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinases. Novel targets for directed cancer therapy.
    Yu AE; Hewitt RE; Connor EW; Stetler-Stevenson WG
    Drugs Aging; 1997 Sep; 11(3):229-44. PubMed ID: 9303281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective matrix metalloproteinase (MMP) inhibitors in cancer therapy: ready for prime time?
    Zucker S; Cao J
    Cancer Biol Ther; 2009 Dec; 8(24):2371-3. PubMed ID: 19959934
    [No Abstract]   [Full Text] [Related]  

  • 17. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment.
    Zucker S; Cao J; Chen WT
    Oncogene; 2000 Dec; 19(56):6642-50. PubMed ID: 11426650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of matrix metalloproteinase inhibitors in cancer therapy.
    Purcell WT; Rudek MA; Hidalgo M
    Hematol Oncol Clin North Am; 2002 Oct; 16(5):1189-227. PubMed ID: 12512389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinase inhibitors: present achievements and future prospects.
    Denis LJ; Verweij J
    Invest New Drugs; 1997; 15(3):175-85. PubMed ID: 9387040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinases in tumorigenesis: an evolving paradigm.
    Hua H; Li M; Luo T; Yin Y; Jiang Y
    Cell Mol Life Sci; 2011 Dec; 68(23):3853-68. PubMed ID: 21744247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.